Madrigal Pharmaceuticals, Inc. Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.

MDGL

株式のランク #2015
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical... Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development phase, concentrating its efforts on discovering and commercializing innovative treatments for cardiovascular, metabolic, and liver disorders. Its most advanced drug candidate, resmetirom, functions as a liver-targeted selective thyroid hormone receptor-ß agonist, currently undergoing late-stage (Phase III) clinical trials for managing non-alcoholic steatohepatitis (NASH). The company's pipeline also features MGL-3745, which serves as a secondary or backup compound to resmetirom. Madrigal holds a collaborative agreement with Hoffmann-La Roche, encompassing research, development, and commercialization activities. The company's operations are based out of West Conshohocken, Pennsylvania.
株価
$446.50
最終同期: 2026-10-19
時価総額
$10.32B
変化（1日）
-0.72%
変化（1年）
1.48%
国
US
取引 Madrigal Pharmaceuticals, Inc. (MDGL)

カテゴリー

Healthcare
Madrigal Pharmaceuticals, Inc.（MDGL）の株式分割履歴
Madrigal Pharmaceuticals, Inc.株（シンボル：MDGL）は合計で1回の株式分割を実施しました。
最新の株式分割はJul 25, 2016に行われました。
Jul 25, 2016より前に購入されたMDGL株は、現在0.028571428571429MDGL株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
2016-07-25 1:35 x0.028571428571429 x0.028571428571429
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL